Effect of Study Design on Sample Size in Studies Intended to Evaluate Bioequivalence of Inhaled Short‐Acting β‐Agonist Formulations

di Zeng, Yaohui, Singh, Sachinkumar, Wang, Kai, Ahrens, Richard C.
Pubblicato in J Clin Pharmacol (2017)

Efficacy and safety of a unique enteric-coated bicarbonate-buffered pancreatic enzyme replacement therapy in children and adults with cystic fibrosis

di Konstan, Michael W, Accurso, Frank J, Nasr, Samya Z, Ahrens, Richard C, Graff, Gavin R
Pubblicazione 2013

Intersession Variability in Single-Breath Diffusing Capacity in Diabetics without Overt Lung Disease

di Drummond, Michael B., Schwartz, Pamela F., Duggan, William T., Teeter, John G., Riese, Richard J., Ahrens, Richard C., Crapo, Robert O., England, Richard D., MacIntyre, Neil R., Jensen, Robert L., Wise, Robert A.
Pubblicazione 2008

Airway microbiota across age and disease spectrum in cystic fibrosis

di Zemanick, Edith T., Wagner, Brandie D., Robertson, Charles E., Ahrens, Richard C., Chmiel, James F., Clancy, John P., Gibson, Ronald L., Harris, William T., Kurland, Geoffrey, Laguna, Theresa A., McColley, Susanna A., McCoy, Karen, Retsch-Bogart, George, Sobush, Kurtis T., Zeitlin, Pamela L., Stevens, Mark J., Accurso, Frank J., Sagel, Scott D., Harris, J. Kirk
Pubblicato in Eur Respir J (2017)